|
| ID |
DDInter1679 |
| Drug Type |
small molecule |
| Molecular Formula |
C16H15F6N5O |
| Molecular Weight |
407.318
|
| Description |
Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used for the management of type 2 diabetes mellitus.
|
| ATC Classification |
A10BH51
A10BD24
A10BD07
A10BH01
A10BD12
|
| IUPAC Name |
(3R)-3-Amino-1-[3-(Trifluoromethyl)-5H,6H,7H,8H-[1,2,4]Triazolo[4,3-A]Pyrazin-7-Yl]-4-(2,4,5-Trifluorophenyl)Butan-1-One |
| InChI |
Inchi=1S/C16H15F6N5O/C17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/H4,6,9H,1-3,5,7,23H2/T9-/M1/S1 |
| InChI Key |
MFFMDFFZMYYVKS-SECBINFHSA-N |
| Canonical SMILES |
N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F |
| Useful Links |
DrugBank
ChEMBL
PubChem
|